Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
171 studies found for:    Open Studies | "Hearing Disorders"
Show Display Options
Rank Status Study
1 Recruiting Genetic Analysis of Hereditary Disorders of Hearing and Balance
Conditions: Sensorineural Hearing Loss;   Hearing Disorder;   Vestibular Disease
2 Recruiting Non-Syndrome Hereditary Hearing Impairment - Gene Mapping: India/Pakistan Protocol
Condition: Hearing Disorder
3 Not yet recruiting Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss
Conditions: Hearing Loss;   Ear Diseases;   Hearing Disorders;   Otorhinolaryngologic Diseases;   Asymmetrical Hearing Loss;   Single-Sided Deafness
Intervention: Device: HiResolution Bionic Cochlear Implant
4 Not yet recruiting Theory Based SMS Reminders - Text's Impact on Patient Attendance
Conditions: Otorhinolaryngologic Diseases;   Sleep Disorders;   Hearing Disorders
Interventions: Other: Emotional SMS text;   Other: Standard SMS text
5 Recruiting Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness
Conditions: Hearing Loss;   Partial Deafness;   Hearing Disorders;   Ear Diseases;   Otorhinolaryngologic Diseases
Interventions: Device: HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode;   Device: EAS sound processor
6 Recruiting Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations
Conditions: Psychotic Disorders;   Mood Disorders;   Personality Disorders;   Stress Disorders, Post-Traumatic;   Hearing Disorders
Interventions: Device: Eldith DC Stimulator stimulation;   Device: Eldith DC Stimulator sham stimulation
7 Recruiting Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Conditions: Hearing Loss;   Deafness;   Hearing Loss, Sensorineural;   Hearing Disorders;   Ear Diseases
Interventions: Drug: Ancrod;   Drug: Saline solution
8 Recruiting Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Condition: Hearing Loss, Idiopathic Sudden Sensorineural
Interventions: Drug: AM-111 0.4 mg/ml;   Drug: AM-111 0.8 mg/ml;   Other: Placebo
9 Recruiting AM-111 in the Treatment of Acute Inner Ear Hearing Loss
Condition: Hearing Loss
Interventions: Other: Placebo;   Drug: AM-111 0.4 mg/ml;   Drug: AM-111 0.8 mg/ml
10 Not yet recruiting The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults
Conditions: Hearing Loss;   Deafness
Intervention: Device: Neuro Cochlear Implant System
11 Not yet recruiting Evaluation of Subjective Ratings on the CP1000 Sound Processor and Compatible Products
Condition: Hearing Loss
Intervention: Device: CP1000 Sound Processor
12 Not yet recruiting Addressing Barriers to Adult Hearing Healthcare
Conditions: Hearing Loss;   Geriatric Disorder
Interventions: Other: Tele-HS;   Other: PCP encouragement
13 Recruiting Clinical Evaluation of Bass and Treble Controls for CI Subjects
Condition: Hearing Loss
Intervention: Device: Bass and Treble
14 Recruiting Cochlear Implant With Anti-Inflammatory Agent
Condition: Hearing Loss
Interventions: Device: Contour Advance electrode with controlled dose of dexamethasone base;   Device: Contour Advance electrode
15 Recruiting Cerebral Activation and Bilateral Stimulation by Cochlear Implantation in Bilateral Deaf Adults
Condition: Deafness
Interventions: Other: Positron Emission Tomography (PET);   Other: Electroencephalogram (EEG)
16 Recruiting Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
Condition: Noise-induced Hearing Loss
Interventions: Drug: D-methionine;   Drug: Placebo
Condition: Children Deafness
Intervention: Other: musical rhythmic stimulation
18 Recruiting Quest Sound Recover (SR2) vs. Venture SR2
Condition: Hearing Loss
Intervention: Device: hearing aid
19 Not yet recruiting Organization of Ambulatory Telemonitoring of People With Hearing Loss and Having a Cochlear Implant COCHLESURV
Condition: Deafness
Intervention: Other: telemedicine
20 Not yet recruiting Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Conditions: Diabetes Mellitus;   Iron Metabolism Disorders;   Gastroduodenal Ulcer;   Optic Atrophy;   Sensorineural Hearing Loss;   Platelet Dysfunction
Interventions: Drug: Deferiprone;   Drug: Acetylcysteine;   Drug: Sitagliptin and Metformin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years